<SEC-DOCUMENT>0001213900-20-002397-index.html : 20200203
<SEC-HEADER>0001213900-20-002397.hdr.sgml : 20200203
<ACCEPTANCE-DATETIME>20200203161646
ACCESSION NUMBER:		0001213900-20-002397
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20200129
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200203
DATE AS OF CHANGE:		20200203

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KBL MERGER CORP. IV
		CENTRAL INDEX KEY:			0001690080
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				813832378
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38105
		FILM NUMBER:		20568863

	BUSINESS ADDRESS:	
		STREET 1:		150 WEST 56TH STREET SUITE 5901
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		212-319-5555

	MAIL ADDRESS:	
		STREET 1:		150 WEST 56TH STREET SUITE 5901
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k012920_kblmerger.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: f8k012920_kblmerger.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>f8k012920ex2-1_kblmerger.htm
<DESCRIPTION>AMENDMENT NO. 1 TO BUSINESS COMBINATION AGREEMENT, DATED AS OF JANUARY 29, 2020, BY AND AMONG KBL, THE COMPANY, KATEXCO, CBR PHARMA, 180, MERGER SUB AND THE STOCKHOLDER REPRESENTATIVE.
<TEXT>
Document 2 - file: f8k012920ex2-1_kblmerger.htm

</DOCUMENT>
</SEC-DOCUMENT>